End-of-life care for people with likely terminal cancer can be quite variable, and may have indicators of poor care quality as well as running up health spending. A new study attempts to identify reasons for variation and the extent to which it is linked with multiple morbidity. (J. Geriatric Oncology Article) The authors used data from 1991 to 2008 from surveys and Medicare fee-for-service claims to identify patients who had terminal cancer and multiple chronic diseases and functional limitations. They studied use of hospice, death in hospital, use of hospital or ER in the last month of life, and use of aggressive cancer treatment. About 60% of all the patients in the study had a combination of chronic conditions, functional limitations and geriatric syndromes. Older patients were less likely to receive cancer treatment near the end-of-life. People with higher education and income were more likely to receive such treatment. There were no significant differences in race or ethnicity. Admission to a hospital or an ER was lower in older patients, but higher among African-Americans and use of hospice was lower among that group. Therefor, African-Americans were more likely to die in the hospital. Income and education had a U-shaped association with in-hospital death. Age and marital sex were not associated strongly with any of the outcomes. High morbidity was not associated with any outcome, but more functional limitations and presence of geriatric syndrome made it less likely that cancer treatment would be received. From this study, it would appear that there generally are not strong associations with many social determinants and end-of-life care, nor with many general health status issues. This suggests that using these factors as a basis for intervention to ensure more rational use of end-of-life care will be difficult.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…
Commentary
March 19, 2023
Why Ukraine Matters
Not supporting Ukraine is asking for far worse conflicts in the future.
Commentary
March 19, 2023
Tim Walz’ Minnesota Sucks
I am in the free state of Florida right now, but my home state is…